Quarterly ResultMay 13, 2026, 04:12 PM
STAAR Surgical Q1 Net Sales $93.5M; Swings to $5.2M Net Income
AI Summary
STAAR Surgical Company reported a significant financial turnaround for the first quarter ended April 3, 2026, with net sales more than doubling and the company swinging to a net profit from a substantial loss in the prior year. The company incurred merger transaction and related costs of $6.7 million, while restructuring charges significantly decreased. Despite increased cash usage in operating activities, total stockholders' equity saw an increase.
Key Highlights
- Net sales increased by 119.6% to $93.5 million from $42.6 million year-over-year.
- Company swung to a net income of $5.2 million, compared to a net loss of $54.2 million.
- Basic and diluted EPS improved to $0.10 from a loss of $1.10 in the prior year.
- Gross profit rose by 145.9% to $68.9 million from $28.0 million year-over-year.
- Operating income was $8.0 million, a significant improvement from an operating loss of $57.4 million.
- Incurred $6.7 million in merger transaction and related costs during the quarter.
- Restructuring, impairment, and related charges decreased to $2.7 million from $22.7 million.
- Net cash used in operating activities increased to $21.7 million from $5.7 million.
Price Impact
More from STAA